NewsbenzingaInhibrx Biosciences Q2 EPS $(2.34) Beats $(2.39) EstimateAug 13, 2026, 16:35 ET · PublishedSummaryOriginalView sourceArticle summaryPlease check the source for details.An excerpt from the original article.Related companiesINBXINBXView stockLikeCommentsRepostShareComments —CommentLoading comments…
Comments —
Loading comments…